Aim Bulletin

Ondine Biomedical upbeat on cost-saving potential of Steriwave product

By Josh White

Date: Wednesday 09 Apr 2025

(Sharecast News) - Ondine Biomedical said in an update on Wednesday that a new health economic analysis by the York Health Economics Consortium (YHEC) supported significant cost-saving potential from its 'Steriwave' nasal decolonisation technology in reducing surgical site infections across major surgeries in the UK.
The AIM-traded firm said the study...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page